• Biochemistry of prostate health studied with column chromatography
    The biochemistry of prostate health has been investigated with column chromatography

    Preparative

    Biochemistry of prostate health studied with column chromatography

    Column chromatography has been used by a team of researchers to look into the biochemistry processes behind prostate health.

    The scientists, from Brigham Young University, Children's Hospital Boston and Harvard Medical School and Stoelting Co, reveal their findings in a research report in Reproductive Biology and Endocrinology (RB&E).

    Column chromatography was used to analyse steroids incubated with equol as part of in vitro investigation into the biochemistry processes governing equol's impact on prostate health.

    They found maximum and half-maximal binding between equol and 5alpha-dihydrotestosterone occurred with 100 nM and 4.8 nM of equol respectively.

    As a result, prostate weight in rat test subjects decreased, but testosterone, estradiol and luteinising hormone levels were unaffected.

    The researchers conclude that administration of equol could help in maintaining prostate health and with combating disorders associated with 5alpha-dihydrotestosterone mediation.

    RB&E aims to provide information about the latest research developments to endocrinologists working within the industry.

    Events

    H2 Forum

    Mar 04 2025 Berlin, Germany

    NGVS 2025

    Mar 18 2025 Beijing, China

    Forum Labo Paris

    Mar 25 2025 Paris, France

    CISILE 2025

    Mar 31 2025 Beijing, China

    Analytica Vietnam

    Apr 02 2025 Saigon, Vietnam

    View all events

    Redirecting you now.
    Labmate Awards Nominations - Open
    The Labmate Awards for Excellence 2025 seek to recognise innovation, quality and achievement wherever it occurs within the laboratory sector. Launching this year the Labmate Awards for Excellence 2025 will have eleven voting categories chosen to reflect the broad range of noteworthy contributions that have been made across our industry in the past 12 months. Nominate your company Now.